Be part of the knowledge - Global Oncology Academy

Medical News

Medical News
Type 2 Diabetes May Contribute to Racial Disparities in Colorectal Cancer Among Americans
news.wisc.edu
12/07/2023
Read more
Medical News
Replacing Bone Saws with Smart Lasers
unibas.ch
12/07/2023
Read more
Medical News
Texas A&M Receives $1.8 Million NIH Grant to Support Bone Health in People with Down Syndrome
today.tamu.edu
12/06/2023
Read more
Medical News
BrainSpec AI Software Receives FDA Clearance for Noninvasive Brain Chemistry Assessment
practicalneurology.com
12/06/2023
Read more

Popular

Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Project Oncology®
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Detecting ESR1 Mutations in Metastatic Breast Cancer: The Role of Liquid Biopsies
Detecting ESR1 Mutations in Metastatic Breast Cancer: The Role of Liquid Biopsies
Project Oncology®
Detecting ESR1 Mutations in Metastatic Breast Cancer: The Role of Liquid Biopsies
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Pavani Chalasani MD, MPH
  Peer
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
Project Oncology®
Staying Up to Date on Advancements in Triple-Negative Breast Cancer Care
What to Know About ESR1 Mutations in HR+/HER2- Metastatic Breast Cancer
What to Know About ESR1 Mutations in HR+/HER2- Metastatic Breast Cancer
Project Oncology®
What to Know About ESR1 Mutations in HR+/HER2- Metastatic Breast Cancer
- Mariya Rozenblit, MD
  Peer
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
CME/CE
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
0.25 credits
- Ezra Cohen, MD
  Peer
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
  Peer
- Deborah J. Wong, MD, PhD
  Peer
0.25 credits
Expert Panel: How Can We Integrate Patient Preference Data To Support Shared Decision-Making Conversations in mHSPC?
Expert Panel: How Can We Integrate Patient Preference Data To Support Shared Decision-Making Conversations in mHSPC?
MinuteCE®
Expert Panel: How Can We Integrate Patient Preference Data To Support Shared Decision-Making Conversations in mHSPC?
1.00 program credit
- Alicia K. Morgans, MD, MPH
  Peer
- Kelvin A. Moses, MD, PhD, FACS
  Peer
1.00 program credit

CME/CE

MET Inhibition in Metastatic NSCLC “In the Spotlight”
MET Inhibition in Metastatic NSCLC “In the Spotlight”
CME/CE
MET Inhibition in Metastatic NSCLC “In the Spotlight”
0.25 credits
- Paul Paik, MD
  Peer
- D. Ross Camidge, MD, PhD
  Peer
- Keith Kerr, BSc, MB ChB
  Peer
0.25 credits
Choosing Between Doublets and Triplets in mHSPC: What Is the Data?
Choosing Between Doublets and Triplets in mHSPC: What Is the Data?
MinuteCE®
Choosing Between Doublets and Triplets in mHSPC: What Is the Data?
1.00 program credit
- Alicia K. Morgans, MD, MPH
  Peer
1.00 program credit
What Is the Current State of Disparities in Prostate Cancer Care?
What Is the Current State of Disparities in Prostate Cancer Care?
MinuteCE®
What Is the Current State of Disparities in Prostate Cancer Care?
1.00 program credit
- Alicia K. Morgans, MD, MPH
  Peer
- Kelvin A. Moses, MD, PhD, FACS
  Peer
1.00 program credit
Expert Panel: Selecting Treatment in mHSPC: Which Treatment for Which Patient?
Expert Panel: Selecting Treatment in mHSPC: Which Treatment for Which Patient?
MinuteCE®
Expert Panel: Selecting Treatment in mHSPC: Which Treatment for Which Patient?
1.00 program credit
- Kelvin A. Moses, MD, PhD, FACS
  Peer
- Alicia K. Morgans, MD, MPH
  Peer
1.00 program credit

Clinical Practice

Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
Project Oncology®
Early Breast Cancer Care: Omitting Radiation Therapy Linked to Less Fear of Recurrence
ESR1 Mutations in Metastatic Breast Cancer: A Predictor of Poor Prognosis
ESR1 Mutations in Metastatic Breast Cancer: A Predictor of Poor Prognosis
Project Oncology®
ESR1 Mutations in Metastatic Breast Cancer: A Predictor of Poor Prognosis
- Pavani Chalasani MD, MPH
  Peer
- Marcela Mazo Canola, MD
  Peer
What to Know About ESR1 Mutations in HR+/HER2- Metastatic Breast Cancer
What to Know About ESR1 Mutations in HR+/HER2- Metastatic Breast Cancer
Project Oncology®
What to Know About ESR1 Mutations in HR+/HER2- Metastatic Breast Cancer
- Mariya Rozenblit, MD
  Peer
How Testing for Acquired vs. Intrinsic Mutations in HR+/HER2- Metastatic Breast Cancer Differs
How Testing for Acquired vs. Intrinsic Mutations in HR+/HER2- Metastatic Breast Cancer Differs
Project Oncology®
How Testing for Acquired vs. Intrinsic Mutations in HR+/HER2- Metastatic Breast Cancer Differs
- Megan Kruse, MD
  Peer

Programs

Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
CME/CE
Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN
0.25 credits
- Ezra Cohen, MD
  Peer
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
  Peer
- Deborah J. Wong, MD, PhD
  Peer
0.25 credits
Expert Panel: How Can We Integrate Patient Preference Data To Support Shared Decision-Making Conversations in mHSPC?
Expert Panel: How Can We Integrate Patient Preference Data To Support Shared Decision-Making Conversations in mHSPC?
MinuteCE®
Expert Panel: How Can We Integrate Patient Preference Data To Support Shared Decision-Making Conversations in mHSPC?
1.00 program credit
- Alicia K. Morgans, MD, MPH
  Peer
- Kelvin A. Moses, MD, PhD, FACS
  Peer
1.00 program credit
How Nurses and Advanced Practice Clinicians Can Help Patients Navigate a New mHSPC Diagnosis
How Nurses and Advanced Practice Clinicians Can Help Patients Navigate a New mHSPC Diagnosis
MinuteCE®
How Nurses and Advanced Practice Clinicians Can Help Patients Navigate a New mHSPC Diagnosis
1.00 program credit
- Stacy Walker, NP
  Peer
1.00 program credit
Expert Panel: How Does ADT Intensification for mHSPC Affect Future Therapy Options?
Expert Panel: How Does ADT Intensification for mHSPC Affect Future Therapy Options?
MinuteCE®
Expert Panel: How Does ADT Intensification for mHSPC Affect Future Therapy Options?
1.00 program credit
- Alicia K. Morgans, MD, MPH
  Peer
- Kelvin A. Moses, MD, PhD, FACS
  Peer
1.00 program credit